Background illustration for clinical trials search

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter

Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)

for
Mycobacterium Avium-intracellulare Infection,
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: All

Age: 18+

Code: NCT07094711

Phase 2, Recruiting

A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma, Relapse Multiple Myeloma,
Location: Boston MA
Sponsor: David Avigan

Sex: All

Age: 18+

Code: NCT06799026

Phase 1, Recruiting

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

for
Chickenpox
Location: Richmond VA, Coral Gables FL, Miami Lakes FL, Tampa FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 1

Code: NCT06855160

Phase 3, Recruiting

Vaccine Immunity and Inflammation in the Aging Person Living With HIV

for
HIV Infections, Age
Location: Minneapolis MN
Sponsor: Hennepin Healthcare Research Institute

Sex: All

Age: 18+

Code: NCT06514547

Recruiting

ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas

for
Low Grade Glioma of Brain
Location: Durham NC
Sponsor: Katy Peters, MD, PhD

Sex: All

Age: 18+

Code: NCT05609994

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

for
EBV, Epstein-Barr Virus Infection, Infectious Mononucleosis,
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 29

Code: NCT06908096

Phase 1, Recruiting

Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old

for
Shigella
Location: Baltimore MD
Sponsor: Eveliqure Biotechnologies GmbH

Sex: All

Age: 18 - 50

Code: NCT07049159

Phase 2, Recruiting

Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

for
Breast Cancer, Triple Negative Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06435351

Early Phase 1, Recruiting

Safety of the Herpes Zoster Subunit Vaccine in Lupus

for
Systemic Lupus Erythematosus
Location: New York NY, Oklahoma City OK
Sponsor: NYU Langone Health

Sex: All

Age: 18 - 70+

Code: NCT05559671

Phase 4, Recruiting

Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors

for
Pediatric Recurrent Central Nervous System Tumors
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 0 - 25

Code: NCT03988283

Phase 1, Recruiting

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant

for
Cytomegaloviral Infection,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 1 - 21

Code: NCT03354728

Phase 1, Phase 2, Recruiting

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

for
Stage III Hepatocellular Carcinoma AJCC v8,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT03942328

Phase 1, Phase 2, Recruiting

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

for
Warts
Location: Salt Lake City UT
Sponsor: Western Institute for Veterans Research

Sex: All

Age: 18+

Code: NCT05625633

Phase 2, Phase 3, Recruiting

Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT05183854

Phase 2, Recruiting

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Charlottesville VA, Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: Female

Age: 18+

Code: NCT04348747

Phase 2, Recruiting

TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery

for
Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7,
Location: Lebanon NH, Pinehurst NC, Jacksonville FL,
Sponsor: Academic and Community Cancer Research United

Sex: Female

Age: 18+

Code: NCT04197687

Phase 2, Recruiting

Immunogenicity of COVID-19 Vaccination in PLWH

for
HIV Infections
Location: Montreal, Toronto
Sponsor: CIHR Canadian HIV Trials Network

Sex: All

Age: 16+

Code: NCT04894448

Recruiting

KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

for
Colorectal Cancer, Pancreatic Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT06411691

Phase 1, Recruiting

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

for
Sudan Virus Disease
Location: Boston MA, Washington D.C. DC, Lenexa KS
Sponsor: International AIDS Vaccine Initiative

Sex: All

Age: 18 - 50

Code: NCT07565090

Phase 1, Recruiting

Converting HR+ Breast Cancer Into an Individualized Vaccine

for
Breast Cancer
Location: New York NY, Houston TX, Dallas TX
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 18 - 70+

Code: NCT03804944

Phase 2, Recruiting

What vaccine clinical trials are studying now

New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.

Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.

Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.

RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.

Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.

COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.

Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.

Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.

Article preview image

65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

How vaccine trials differ from drug trials

Who can participate in vaccine clinical trials?

Do vaccine trial participants get paid?

How to enroll in a vaccine clinical trial